| Patricia Mae Engel Overcarsh, MD, MPH | |
|
119 Hendersonville Rd, Asheville, NC 28803 | |
| (828) 771-5500 | |
| (828) 257-4750 |
| Full Name | Patricia Mae Engel Overcarsh |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | 119 Hendersonville Rd, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073856506 | NPI | - | NPPES |
| 2019-01671 | Other | NC | MEDICAL LICENSE |
| 1073856506 | Medicaid | NC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain Area Health Education Center Inc | 0143206599 | 129 |
News Archive
GenomeDx Biosciences today announced that the robust Decipher genomic analysis platform, successfully classified various subtypes of bladder cancer based on the genomic expression of certain biomarkers, including one type associated with resistance to cisplatin-based chemotherapy. Importantly, this unique genomic signature has potential as a tool to predict tumor responsiveness to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancers (MIBC).
Health Monitor Network, the leading patient-engagement company, and ProHEALTH Care Associates, LLP, one of the largest integrated physician group practices in the New York metropolitan area, have announced an exclusive partnership designed to enhance the healthcare experience of ProHEALTH's approximately 800,000 patients, both in physician offices and at home.
One of the many mysteries of Alzheimer's disease is how protein-like snippets called amyloid-beta peptides, which clump together to form plaques in the brain, may cause cell death, leading to the disease's devastating symptoms of memory loss and other mental difficulties.
Experts around the world are concerned about the threat to hospitals from 'superbugs' such as MRSA (Methicillin-resistant Staphylococcus aureus) which have developed resistance to most of the antibiotics used to treat them.
Acorda Therapeutics, Inc. today announced that the Company has completed the acquisition of Neuronex, Inc., a privately held company developing a nasal spray formulation of diazepam. Under the terms of the agreement, Acorda paid $6.8 million to Neuronex to complete the acquisition.
› Verified 9 days ago
| Entity Name | Mountain Area Health Education Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952356388 PECOS PAC ID: 0143206599 Enrollment ID: O20040625000988 |
News Archive
GenomeDx Biosciences today announced that the robust Decipher genomic analysis platform, successfully classified various subtypes of bladder cancer based on the genomic expression of certain biomarkers, including one type associated with resistance to cisplatin-based chemotherapy. Importantly, this unique genomic signature has potential as a tool to predict tumor responsiveness to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancers (MIBC).
Health Monitor Network, the leading patient-engagement company, and ProHEALTH Care Associates, LLP, one of the largest integrated physician group practices in the New York metropolitan area, have announced an exclusive partnership designed to enhance the healthcare experience of ProHEALTH's approximately 800,000 patients, both in physician offices and at home.
One of the many mysteries of Alzheimer's disease is how protein-like snippets called amyloid-beta peptides, which clump together to form plaques in the brain, may cause cell death, leading to the disease's devastating symptoms of memory loss and other mental difficulties.
Experts around the world are concerned about the threat to hospitals from 'superbugs' such as MRSA (Methicillin-resistant Staphylococcus aureus) which have developed resistance to most of the antibiotics used to treat them.
Acorda Therapeutics, Inc. today announced that the Company has completed the acquisition of Neuronex, Inc., a privately held company developing a nasal spray formulation of diazepam. Under the terms of the agreement, Acorda paid $6.8 million to Neuronex to complete the acquisition.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Mae Engel Overcarsh, MD, MPH 119 Hendersonville Rd, Asheville, NC 28803-2868 Ph: (828) 771-5500 | Patricia Mae Engel Overcarsh, MD, MPH 119 Hendersonville Rd, Asheville, NC 28803 Ph: (828) 771-5500 |
News Archive
GenomeDx Biosciences today announced that the robust Decipher genomic analysis platform, successfully classified various subtypes of bladder cancer based on the genomic expression of certain biomarkers, including one type associated with resistance to cisplatin-based chemotherapy. Importantly, this unique genomic signature has potential as a tool to predict tumor responsiveness to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancers (MIBC).
Health Monitor Network, the leading patient-engagement company, and ProHEALTH Care Associates, LLP, one of the largest integrated physician group practices in the New York metropolitan area, have announced an exclusive partnership designed to enhance the healthcare experience of ProHEALTH's approximately 800,000 patients, both in physician offices and at home.
One of the many mysteries of Alzheimer's disease is how protein-like snippets called amyloid-beta peptides, which clump together to form plaques in the brain, may cause cell death, leading to the disease's devastating symptoms of memory loss and other mental difficulties.
Experts around the world are concerned about the threat to hospitals from 'superbugs' such as MRSA (Methicillin-resistant Staphylococcus aureus) which have developed resistance to most of the antibiotics used to treat them.
Acorda Therapeutics, Inc. today announced that the Company has completed the acquisition of Neuronex, Inc., a privately held company developing a nasal spray formulation of diazepam. Under the terms of the agreement, Acorda paid $6.8 million to Neuronex to complete the acquisition.
› Verified 9 days ago
Dr. Ruchi Patel Moore, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 41 Oakland Rd, Suite 200, Asheville, NC 28801 Phone: 828-253-5381 Fax: 828-253-9087 | |
Dr. Ursula Fritzi Harkness, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 119 Hendersonville Rd, Asheville, NC 28803 Phone: 828-771-5504 Fax: 828-771-5479 | |
Dr. Summer Kimberly Gilmer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 41 Oakland Road, Suite 200, Asheville, NC 28801 Phone: 828-253-5381 Fax: 828-253-9087 | |
Elizabeth S. Garbarino, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 40 N Merrimon Ave, Asheville, NC 28804 Phone: 828-575-9562 Fax: 828-575-2884 | |
Sarah Jones, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 143 Asheland Ave, Asheville, NC 28801 Phone: 828-258-9191 | |
Bhaskari Burra, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 119 Hendersonville Rd, Asheville, NC 28803 Phone: 828-771-5500 Fax: 828-257-4750 |